Valneva and and Instituto Butantan, producer of immunobiologic products, today announced the signing of definitive agreements for the development,…
How multiple enhancer elements cooperate to drive expression of their target gene is poorly understood. New research from the lab of Christa Bücker…
380 million years ago, fish started to crawl out of the water to colonise land. The Australian lungfish – an endangered, air-breathing fish – is one…
Despite modern sequencing methods, determining the precise sequence of the genetic code for ribosomal RNA (rRNA) has been technically challenging due…
Valneva announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine,…
Changes in daylength are a well-established annual timing cue for animal behavior and physiology. An international collaboration of scientists led by…
Valneva announced it has appointed Perry Celentano as Chief Operating Officer (COO) on an interim basis to support the expansion of the manufacturing…
New toxin-antidote pairs discovered in nematode species – researchers from the Burga lab at IMBA – Institute of Molecular Biotechnology of the…
Valneva reported preliminary and unaudited cash and cash equivalents of €204.4 million at the end of December 2020, exceeding its guidance of between…
The Austrian Science Fund (FWF) has granted a second four-year funding period for the Doctoral Program “Signaling Mechanisms in Cellular Homeostasis”…
Valneva announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
Read more
Nicolas Rivron, group leader at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences receives an ERC consolidator grant to…
The website uses cookies to ensure you get the best experience on our website.
Anonymous evaluation for troubleshooting and further development
Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics Storage period: data on your device for up to two years. Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.
